No, Do Not Increase Methimazole When TSH is Low
When TSH is low during methimazole treatment, you should DECREASE the methimazole dose, not increase it. A low TSH indicates the patient is becoming hypothyroid from excessive antithyroid medication 1.
Understanding the Monitoring Logic
The FDA label explicitly states: "Once clinical evidence of hyperthyroidism has resolved, the finding of a rising serum TSH indicates that a lower maintenance dose of methimazole should be employed" 1. This means:
- Low/suppressed TSH = Still hyperthyroid or becoming euthyroid → Continue current dose or reduce if free T4 is normal
- Rising TSH = Becoming hypothyroid → Reduce methimazole dose
- Normal TSH = Euthyroid → Maintain current dose
The Critical Pitfall: TSH Lag Time
A common error is misinterpreting a suppressed TSH early in treatment. TSH levels may remain suppressed for a month or longer after hyperthyroidism resolves 2. During this lag period, you must interpret TSH cautiously and always in concert with free T4 and T3 levels 2.
Practical Monitoring Algorithm:
- If TSH is low AND free T4/T3 are elevated: Patient is still hyperthyroid → Continue or increase methimazole
- If TSH is low BUT free T4/T3 are normal: TSH lag phenomenon → Maintain current dose, recheck in 4-6 weeks
- If TSH is low AND free T4/T3 are low: Overtreatment causing hypothyroidism → Decrease methimazole immediately
- If TSH is rising toward normal: Appropriate response → Continue current dose
Treatment Goals
The goal during methimazole therapy is to maintain euthyroidism, not to normalize TSH immediately 2. In pregnancy specifically, guidelines recommend keeping free T4 at or slightly above the upper limit of normal with TSH suppressed 2, demonstrating that TSH suppression alone is not the treatment target.
Avoiding Overtreatment
Overt hypothyroidism should be avoided 2, particularly in patients with active Graves' ophthalmopathy. Over-replacement with thyroid hormone suppression has been associated with adverse cardiovascular and skeletal events in population studies 3.
Monitor thyroid function tests periodically during therapy 1. When patients become euthyroid on methimazole, the typical maintenance dose is 5-10 mg daily 2, down from initial doses of 10-20 mg daily.